Malaria - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Pipeline Review, H1 2017, provides an overview of the Malaria (Infectious Disease) pipeline landscape.
Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malari
Read More
- List of Tables
- Number of Products under Development for Malaria, H1 2017
- Number of Products under Development by Companies, H1 2017
- Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
- Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
- Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
- Number of Products under Development by Universities/Institutes, H1 2017
- Number of Products under Development by Universities/Insti
Read More
- Table of Contents
- Table of Contents 2
- Introduction 5
- Malaria - Overview 6
- Malaria - Therapeutics Development 7
- Malaria - Therapeutics Assessment 30
- Malaria - Companies Involved in Therapeutics Development 41
- Malaria - Drug Profiles 69
- Malaria - Dormant Projects 319
- Malaria - Discontinued Products 327
- Malaria - Product Development Milestones 329
- Appendix 344
Read More